TriCor Data Close At Hand; Will It Strike ACCORD With Physicians?
This article was originally published in The Pink Sheet Daily
Executive Summary
Cardiovascular outcomes data comparing fenofibrate and simvastatin versus just the statin could have implications for Abbott's cholesterol franchise.